Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Stress Ball and Empathic Verbal-Tactile Interventions for Reducing Anxiety and Pain in Mammography and Breast Ultrasonography: A Randomized Trial

25 april 2026 uppdaterad av: Betül Güven, Istanbul University

Effects of Stress Ball Use and Empathic Verbal Communication With Therapeutic Touch on Anxiety and Pain Perception in Women Undergoing Mammography and Breast Ultrasonography: A Randomized Controlled Trial

This prospective, randomized controlled trial aims to determine the effects of stress ball use and empathic verbal communication with therapeutic touch on anxiety and pain perception in women undergoing mammography and breast ultrasonography. The study will be conducted between May and September 2026 at Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital.

A total of 122 women meeting the inclusion criteria will be randomly assigned into three groups: stress ball group (n=41), empathic verbal communication with touch group (n=41), and control group (n=40). Women in the stress ball group will be instructed to use a soft stress ball before and during the procedure. Participants in the empathic verbal-tactile group will receive structured verbal empathy combined with therapeutic touch. The control group will receive routine care without additional intervention.

Data will be collected before and after the procedures using a Descriptive Characteristics Form, the State-Trait Anxiety Inventory, and a Numerical Rating Scale for pain assessment. The findings of this study are expected to provide evidence on the effectiveness of non-pharmacological interventions in reducing anxiety and pain during breast imaging procedures.

Studieöversikt

Detaljerad beskrivning

This study is designed as a prospective, parallel-group randomized controlled trial to examine the effects of stress ball use and empathic verbal communication combined with therapeutic touch on anxiety levels and pain perception in women undergoing mammography and breast ultrasonography. The research will be carried out between May and September 2026 at Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital.

Prior to participant recruitment, all necessary ethical approvals will be secured. Eligible women presenting for mammography and breast ultrasonography will be informed about the study purpose, procedures, and voluntary nature of participation, and written informed consent will be obtained. Inclusion criteria consist of being 18 years of age or older, undergoing these imaging procedures for the first time, being literate, and having no sensory or motor impairment affecting the upper extremities. Women with previous experience of these procedures, as well as those with cognitive, physical, visual, or hearing impairments, will be excluded.

The sample size was determined as 122 participants based on a 95% confidence level and 5% margin of error. Participants will be allocated into three groups in a 1:1:1 ratio: stress ball group (n=41), empathic verbal communication with therapeutic touch group (n=41), and control group (n=40).

Randomization and Allocation Procedure Participants will be randomized individually on the day of their scheduled mammography and breast ultrasonography appointments. After confirming eligibility and obtaining written informed consent, participants will be assigned to one of three groups (stress ball, empathic verbal communication with therapeutic touch, or control) using a computer-generated randomization sequence.

Block randomization with a 1:1:1 allocation ratio will be used to ensure balanced group sizes throughout the study period. The randomization list will be prepared in advance by an independent researcher who is not involved in recruitment, intervention delivery, or data collection.

To maintain allocation concealment, group assignments will be placed in sequentially numbered, opaque, sealed envelopes. These envelopes will be opened only after participant enrollment, in the order of inclusion.

Randomization will be implemented continuously on a daily basis as participants present for their scheduled appointments, ensuring that group assignment remains unpredictable and independent of appointment timing.

Due to the nature of the interventions, blinding of participants and intervention providers is not feasible. However, outcome data will be collected using standardized and validated self-report instruments to minimize bias.

Intervention Procedures Participants assigned to the stress ball group will be provided with a soft, smooth stress ball (6 cm in diameter) and instructed to repeatedly squeeze and relax it while waiting for the procedure and during ultrasonography.

Participants in the empathic verbal communication with therapeutic touch group will be taken to a quiet waiting area. Trained researchers will use predefined empathic statements and simultaneously apply gentle touch by placing a hand on the participant's shoulder.

Participants in the control group will receive routine clinical care without any additional intervention.

Data Collection and Outcomes Data will be collected immediately before and after the imaging procedures. A Descriptive Characteristics Form will be used to obtain sociodemographic and clinical information. Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI), and pain intensity will be measured using a Numerical Rating Scale ranging from 0 (no pain) to 10 (worst possible pain).

The primary aim of the study is to evaluate the effectiveness of these non-pharmacological interventions in reducing anxiety and perceived pain during breast imaging procedures.

Data Analysis Statistical analyses will be conducted using statistical software. Descriptive statistics will summarize baseline characteristics. Between-group differences in anxiety and pain scores will be assessed using appropriate tests based on data distribution (e.g., one-way ANOVA or Kruskal-Wallis test), while within-group changes will be analyzed using paired comparisons. Post hoc analyses will be performed where applicable. Statistical significance will be set at p < 0.05.

Studietyp

Interventionell

Inskrivning (Beräknad)

122

Fas

  • Inte tillämpbar

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Female participants aged 18 years and older
  • Scheduled to undergo mammography and breast ultrasonography
  • Undergoing these imaging procedures for the first time
  • Literate (able to read and understand study materials)
  • No sensory or motor impairment affecting the upper extremities (hands/arms)
  • Willing to participate and able to provide written informed consent

Exclusion Criteria:

  • Previous experience of mammography or breast ultrasonography
  • Presence of any cognitive impairment that may affect understanding or communication
  • Presence of any physical disability that may interfere with participation
  • Hearing or visual impairment that may hinder communication or completion of study procedures
  • Refusal to participate or inability to provide informed consent

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Stress Ball Intervention
Participants in this group will be provided with a soft, smooth stress ball (approximately 6 cm in diameter) before the imaging procedure. They will be instructed to rhythmically squeeze and relax the ball while waiting for the procedure and to continue its use during breast ultrasonography.
Participants will be provided with a soft, smooth stress ball (approximately 6 cm in diameter) prior to the imaging procedure. They will be instructed to rhythmically squeeze and release the ball while waiting for mammography and to continue using it during breast ultrasonography until the procedure is completed.
Experimentell: Empathic Verbal Communication with Therapeutic Touch
Participants in this group will be guided to a quiet waiting area where trained researchers will deliver standardized empathic verbal statements. Simultaneously, gentle therapeutic touch will be applied by placing a hand on the participant's shoulder to provide reassurance and emotional support prior to the procedure.
Empathic Verbal Communication with Therapeutic Touch (Behavioral) Participants will be taken to a quiet waiting area before the procedure. Trained researchers will deliver standardized empathic verbal statements to provide reassurance and emotional support. At the same time, gentle therapeutic touch will be applied by placing a hand on the participant's shoulder. The intervention will be administered prior to the imaging procedure.
Inget ingripande: Control (Routine Care)
Participants in the control group will receive routine clinical care without any additional intervention beyond standard practice.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Anxiety Level
Tidsram: Immediately before and immediately after mammography and breast ultrasonography (same day)
Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI). Higher scores indicate higher levels of anxiety
Immediately before and immediately after mammography and breast ultrasonography (same day)
Pain Intensity
Tidsram: Immediately after mammography and breast ultrasonography (same day)
Pain intensity will be evaluated using a Numerical Rating Scale (0-10), where 0 indicates no pain and 10 indicates the worst possible pain.
Immediately after mammography and breast ultrasonography (same day)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

4 maj 2026

Primärt slutförande (Beräknad)

14 september 2026

Avslutad studie (Beräknad)

30 september 2026

Studieregistreringsdatum

Först inskickad

25 april 2026

Först inskickad som uppfyllde QC-kriterierna

25 april 2026

Första postat (Faktisk)

1 maj 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

1 maj 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

25 april 2026

Senast verifierad

1 april 2026

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera